Both etanercept (Enbrel) and infliximab (Remicade) have been shown to be effective in the treatment of psoriasis and psoriatic arthritis in randomized, double-blind, placebo-controlled trials.
Arthritis News
Abatacept Receives FDA Approval for Treatment of RA
The Food and Drug Administration (FDA) has now approved abatacept (Orencia®) for the treatment of rheumatoid arthritis (RA). It is the first approved agent to demonstrate efficacy and safety in patients with an inadequate response to TNF antagonists, as well as those with an inadequate response to MTX.
Improved Cardio-Respiratory Fitness with Prescribed Exercise
Regular physical activity improves general health but the frequency and intensity of physical activity required to produce benefits is not clear. To address this issue, Duncan and associates (Archives of Internal Medicine, 2005; 165: 2362-2369) conducted a randomized controlled clinical trial to evaluate the effects of different prescriptions of exercise intensity and frequency on cardiovascular disease risk factors.
Consequences of Physical Activity on Life Expectancy
[…]
Medicare Part D – Medicare’s New Prescription Drug Program
[…]
Intra-articular Transfer of Genes has Therapeutic Potential in Inflammatory Arthritis
[…]
